INS and cancer: Another study showed that miR-486-5p could inhibit proliferation, migration and invasion of cancer in vitro and suppress hepatocellular carcinoma (HCC) growth in vivo by targeting phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1), which plays an important role in the metabolic actions of insulin.